Cost-Effectiveness of Intensive Atorvastatin Therapy in Secondary Cardiovascular Prevention in the United Kingdom, Spain, and Germany, Based on the Treating to New Targets Study
Douglas C. A. Taylor, Ankur Pandya, David Thompson, Paula Chu, Jennifer Graff, James Shepherd, Nanette Wenger, Heiner Greten, Rafael Carmena, Michael Drummond and Milton C. WeinsteinVolume:
10
Language:
english
Journal:
The European Journal of Health Economics
DOI:
10.2307/40283782
Date:
July, 2009
File:
PDF, 1.80 MB
english, 2009